THERACLE
LIVE

Serial Number

97055312

Owner

Theracle, Inc.

Attorney

Mary Margaret L. O'Donnell

Filing Date

Sep 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

THERACLE Trademark

Serial Number: 97055312

THERACLE is a trademark filed by Theracle, Inc. on September 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Theracle, Inc.

12500 Network Blvd., Ste. 112
San Antonio, TX 78249

Entity Type: 03

Trademark Details

Filing Date

September 30, 2021

Registration Date

Not Registered

Published for Opposition

January 16, 2024

Goods & Services

Implantable drug delivery devices sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug reservoir devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug refill devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies

Medical device in the form of an implant for medical diagnosis, treatment, or medication release sold empty, namely, implantable drug delivery devices; surgical implants comprised of artificial material; implantable drug delivery ports; drug reservoir devices sold empty used for administering drugs, namely, implantable drug reservoirs; drug refill devices sold empty used for administering drugs, namely, drug refillers

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2026 EXRA
SOU EXTENSION 4 GRANTED
Mar 2, 2026 EX4G
SOU EXTENSION 4 FILED
Mar 2, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 2, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 11, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 11, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 4, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 10, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 10, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 11, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 23, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 7, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 30, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2021 NWOS
NEW APPLICATION ENTERED
Oct 4, 2021 NWAP